SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-012975
Filing Date
2018-05-10
Accepted
2018-05-10 16:25:19
Documents
51
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nktr-10q_20180331.htm 10-Q 1139956
2 EX-4.1 nktr-ex41_103.htm EX-4.1 371268
3 EX-10.1 nktr-ex101_104.htm EX-10.1 1419424
4 EX-31.1 nktr-ex311_8.htm EX-31.1 16066
5 EX-31.2 nktr-ex312_6.htm EX-31.2 16078
6 EX-32.1 nktr-ex321_9.htm EX-32.1 7771
  Complete submission text file 0001564590-18-012975.txt   6133524

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT nktr-20180331.xml EX-101.INS 784657
8 XBRL TAXONOMY EXTENSION SCHEMA nktr-20180331.xsd EX-101.SCH 45349
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nktr-20180331_cal.xml EX-101.CAL 43191
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nktr-20180331_def.xml EX-101.DEF 126310
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktr-20180331_lab.xml EX-101.LAB 310337
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktr-20180331_pre.xml EX-101.PRE 230251
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 18822909
SIC: 2834 Pharmaceutical Preparations